These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 25440760

  • 1. S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells.
    Kang M, Lee HS, Lee YJ, Choi WS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C.
    Urology; 2015 Jan; 85(1):273.e9-15. PubMed ID: 25440760
    [Abstract] [Full Text] [Related]

  • 2. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M, Lee KH, Lee HS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C.
    Prostate; 2016 Feb 15; 76(3):273-85. PubMed ID: 26499308
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J, Hou J, Gao X, Xu C, Huang J, Zhao Y, Sun Y.
    J Urol; 2013 Dec 15; 190(6):2278-87. PubMed ID: 23845456
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. STAT3 phosphorylation is required for the HepaCAM-mediated inhibition of castration-resistant prostate cancer cell viability and metastasis.
    Tan B, Chen X, Fan Y, Yang Y, Yang J, Tan L.
    Prostate; 2021 Jun 15; 81(9):603-611. PubMed ID: 33909312
    [Abstract] [Full Text] [Related]

  • 13. Small leucine zipper protein promotes the metastasis of castration-resistant prostate cancer through transcriptional regulation of matrix metalloproteinase-13.
    Kim S, Kang M, Ko J.
    Carcinogenesis; 2021 Aug 19; 42(8):1089-1099. PubMed ID: 34050742
    [Abstract] [Full Text] [Related]

  • 14. Dihydrotestosterone enhances castration-resistant prostate cancer cell proliferation through STAT5 activation via glucocorticoid receptor pathway.
    Song C, Kim Y, Min GE, Ahn H.
    Prostate; 2014 Sep 19; 74(12):1240-8. PubMed ID: 25043756
    [Abstract] [Full Text] [Related]

  • 15. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
    London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR.
    Cancer Gene Ther; 2003 Nov 19; 10(11):823-32. PubMed ID: 14605668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
    Shi SJ, Wang LJ, Han DH, Wu JH, Jiao D, Zhang KL, Chen JW, Li Y, Yang F, Zhang JL, Zheng GX, Yang AG, Zhao AZ, Qin WJ, Wen WH.
    Theranostics; 2019 Nov 19; 9(5):1247-1263. PubMed ID: 30867828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.